I’m grateful for the journey that has allowed me to grow as a surgeon, leader, and advisor across healthcare, business, and service. From restoring function in patients’ lives to building and leading organizations, each experience has shaped my commitment to excellence and impact. I look forward to continuing this path of leadership and service. Here is my biography.

Dr. Violanda Grigorescu is a globally recognized leader in public health, clinical science, and biomedical informatics with over 40 years of experience spanning federal, state, and international roles. She has held senior positions at the NIH, CDC, and Michigan Department of Community Health, where she led transformative initiatives in maternal and child health, health data infrastructure, and epidemiologic research. Known for building collaborative ecosystems across agencies and disciplines, Dr. Grigorescu has pioneered groundbreaking programs integrating AI, FHIR standards, and advanced analytics to improve health outcomes and policy. Her career reflects a rare blend of clinical expertise, strategic leadership, and a deep commitment to equity and innovation in healthcare systems.

Christopher Roche is a seasoned medical device executive with over 23 years of experience driving innovation in orthopedic technology and global commercialization. As Senior Vice President of Extremities at Exactech, he has led the division’s transformation into a $200 million business while contributing over 140 peer-reviewed publications and securing 38 patents. A member of the AIMBE College of Fellows and a recognized thought leader, Christopher blends deep biomedical engineering expertise with strategic vision and a passion for mentoring and global collaboration.

After more than 30 years immersed in the world of cell and gene therapy, I've had the privilege to lead, innovate, and mentor across academic, clinical, and industry landscapes. From cleanroom design to regulatory submissions and teaching future leaders, my journey has been defined by purpose and progress. Here is my biography.

I'm grateful for the opportunities and experiences that have shaped my journey in the healthcare and medical device industries. With a focus on servant leadership, strategic marketing, and product innovation, I've always sought to create meaningful impact by empowering others and aligning with purpose-driven missions. Here is my biography.

Dr. Hassan Razvi is a globally respected healthcare innovator and urological surgeon with over three decades of experience advancing medical research, device development, and clinical excellence. Known for his leadership in early-stage product innovation through to clinical trials, he has contributed extensively to the global medical community through board service, international collaboration, and impactful communication. Dr. Razvi's ability to translate complex clinical insights into strategic direction makes him a valuable advisor to companies aiming to grow and innovate in the healthcare, pharmaceutical, and medical device industries.

Dr. Andrew King is a distinguished orthopedic surgeon, medical educator, and innovator in pediatric scoliosis treatment, with over 40 years of experience in spinal deformity care, surgical advancements, and medical research. A recognized leader in his field, he has served as Chairman of Orthopedic Surgery at LSU Health Sciences Center and played a pivotal role in shaping pediatric orthopedic education and surgical techniques. His expertise extends beyond clinical practice, as he has consulted for leading medical device companies, contributed to groundbreaking research, and lectured globally on spinal deformities. As G. Dean MacEwen Professor Emeritus, Dr. King continues to bridge the gap between medical innovation and business strategy, seeking to contribute his deep industry knowledge and leadership to organizations dedicated to advancing healthcare and medical technology.

Deb Kelly is a pioneering leader in biomedical research, known for her expertise in molecular biophysics, computational modeling, and high-resolution imaging to advance translational medicine. As Executive Director of Structural Oncology LLC and a professor at Penn State University, she has led groundbreaking research in cancer and viral health threats, integrating artificial intelligence and bioinformatics to drive drug discovery and clinical decision-making. With over 15 years of experience managing multidisciplinary teams, securing millions in research funding, and mentoring early-career professionals, Kelly’s work has had a lasting impact on biomedical science. Her strategic leadership, innovative research, and commitment to mentorship continue to shape the future of medical advancements and therapeutic development.

Innovation diplomacy serves as a powerful force in bridging nations, fostering scientific collaboration, and driving global progress. Through strategic alliances in fields like high-energy physics, renewable energy, and medical research, countries can work together to address pressing challenges while strengthening diplomatic ties. Initiatives such as the U.S.-India accelerator technology partnership and global projects like CERN and the International Space Station highlight the transformative potential of international scientific cooperation. Despite challenges like geopolitical tensions and intellectual property concerns, the future of innovation diplomacy holds promise for shaping sustainable solutions, advancing technology, and promoting peaceful collaboration across borders.

Eric Trac is a visionary healthcare investor and biopharmaceutical strategist with a unique blend of medical expertise and financial acumen, driving transformative growth in the healthcare sector. As a Senior Analyst & Director at Sarissa Capital Management, he leads activist investment strategies, evaluates public and private market opportunities, and serves as a board director at Lyndra Therapeutics. With a background in venture capital at Vida Ventures and Vivo Capital, he has played a pivotal role in high-impact transactions, including Bayer’s $4 billion acquisition of AskBio and Centessa Pharmaceuticals’ $250 million Series A. Trac’s deep scientific foundation stems from his MD and MBA from Stanford University and his research in biotechnology at MIT, where he graduated in the top 8% of his class. Recognized as one of *Business Insider’s* “14 Most Impressive Students at MIT,” he continues to leverage his expertise in medicine and finance to drive innovation, maximize shareholder value, and advance the future of biopharmaceuticals.

I’m excited to share my executive biography, highlighting my experience in R&D, regulatory strategy, and product innovation within the medical device industry. As I transition into board and advisory roles, I look forward to leveraging my expertise to help med-tech companies scale, innovate, and navigate regulatory landscapes.

Technology is transforming cancer diagnosis and treatment, offering new opportunities to improve global health outcomes, particularly in underserved regions. Innovations such as telepathology, advanced imaging, and AI-based tools are bridging the gap between healthcare providers and specialized expertise, enhancing diagnostic accuracy and speeding up treatment processes. However, challenges like infrastructure limitations, cost, and data security need to be addressed for successful implementation. This article explores these technological advancements, their real-world applications, and offers key recommendations for healthcare leaders looking to adopt similar solutions in cancer care. #CancerCare #Telepathology #AIInHealthcare #AdvancedImaging #GlobalHealth #HealthcareInnovation

Happy to share the remarkable journey of Heather Pidcoke, a leader in translational research benefiting both human and veterinary patients. Her integrity, deep expertise, strategic vision, and effective communication skills drive groundbreaking advancements in biomedical sciences. Discover how Heather is shaping the future of medical innovation.